Li, Pengfei
Du, Ping
Peng, Jun
Zhao, Zhixia
Li, Huiling
Yu, Weiyue
Wang, Shumin
Liu, Lihong
Funding for this research was provided by:
Capital’s Funds for Health Improvement and Research (2020-1-2031)
Article History
Received: 23 August 2023
Accepted: 27 December 2023
First Online: 2 January 2024
Declarations
:
: This study has been approved by the ethics committee of Beijing Chao-yang Hospital, Capital Medical University (BCYH-CMU) with the ethical approval number 2016-drug-45, and all volunteers provided with informed written consent in BCYH-CMU. Any change to the protocol will be approved by the relevant regulatory authorities and require participants to re-consent before continuing in the study. This trial is conducted by the Declaration of Helsinki and Good Clinical Practice Guidelines and all patients provided written informed consent.
: Not applicable.
: The authors declare no competing interests.